Upstream Bio logo

Upstream Bio

UPB | NASDAQ
Chart Builder DCF Calculator
$2.15
-$0.63 (-22.66%)
At close: Nov 16, 2026, 4:00 PM ET
$2.19
+$0.04 (+1.64%)
After-hours: Nov 16, 2026, 7:36 PM ET
-22.66%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
42.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #468/1021 (Top 46%)

Key Statistics

Market Data

Market Cap $117.84M
1D Range
2.12 2.83
52W Range
2.12 32.60

Valuation (TTM)

PE -0.71
PB 0.50
EV/EBITDA 0.54

Valuation (NTM)

Forward PE N/A
Forward PEG -0.09
Price Target $25.00
Loading financial charts...

Profile

Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory syst...

Sector Healthcare
Industry Biotechnology
Employees 75
IPO Date Oct 11, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.75
Miss -2.55%
REV
$395K
Miss -28.02%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$25.00
Upside
+1062.79%
Buy (3)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.